| Filed On | Filing |
|---|---|
| 04 Aug 2026 |
Form 3: Nicacio Leonardo Viana, Chief Medical Officer
No securities owned |
| 22 May 2026 |
Form 3: Saxena Nishant C, Chief Business Officer
Holds 3,500 shares of Common Stock, par value $0.0001 per share |
| 21 May 2026 |
Form 3: Pfeiffenberger Brent, Director
No securities owned |
| 18 Mar 2025 |
Form 3: Hodgson Ian, Chief Operating Officer
Holds 1,234 shares of Common Stock, par value $0.0001 per share |
| 20 Aug 2024 |
Form 3: Kung Winston, Director
No securities owned |
| 29 Feb 2024 |
Form 3: Smethurst Dominic, Chief Medical Officer
No securities owned |
| 30 Jan 2024 |
Form 3: Cormorant Asset Management, Lp, 10% owner and 2 others
Holds 442,368 shares of Common Stock |
| 07 Mar 2023 |
Form 3: Ben Yong, Director
No securities owned |
| 28 Sep 2022 |
Form 3: Altmeyer Anne, Director
No securities owned |
| 08 Dec 2021 |
Form 3: Brake Rachael Louise, Chief Scientific Officer
No securities owned |
| 08 Jul 2020 |
Form 3: Golumbeski George, Director
No securities owned |
| 10 Mar 2020 |
Form 3: Salzmann Peter, Director
No securities owned |
| 08 Aug 2019 |
Form 3: Discordia Robert Paul, Chief Operating Officer
Holds 15,150 shares of Common stock |
| 08 Apr 2019 |
Form 3: Jacques Rachelle Suzanne, Director
No securities owned |
| 04 Mar 2019 |
Form 3: Millian Craig Stuart, Chief Commercial Officer
No securities owned |
| 06 Jun 2018 |
Form 3: Jenkins John Kenneth, Director
No securities owned |
| 18 Oct 2017 |
Form 3: Panayiotopoulos Paris, Director
No securities owned |
| 05 Aug 2015 |
Form 3: Knoll Capital Management, Lp, 10% owner
Holds 2,750,000 shares of Common Stock |
| 16 Jul 2015 |
Form 3: Burstein Sumner, 10% owner
Holds 3,825,546 shares of Common Stock |
| 25 Nov 2014 |
Form 3: Tepper Mark, President and CSO
Holds 2,099,000 shares of Common Stock |
Loading...
